Development Level

Tchem 2 | 1,890
Tbio 1 | 10,625
Tclin 1 | 602

Disease

Cancer 4 | 2,346
psoriasis 4 | 6,685
Anemia 3 | 252
Hypersensitivity reaction type II disease 3 | 235
Kidney disease 3 | 396
Malaria 3 | 140
Severe Combined Immunodeficiency 3 | 46
diabetes mellitus 3 | 1,663
medulloblastoma, large-cell 3 | 6,234
Acquired immunodeficiency syndrome 2 | 164
Alopecia areata 2 | 37
Alzheimer's disease 2 | 644
Autistic Disorder 2 | 320
Bladder Neoplasm 2 | 109
Dermatitis, Allergic Contact 2 | 66
Diarrhea 2 | 155
Glomerulonephritis 2 | 36
HIV Infections 2 | 100
Heart disease 2 | 279
Hemochromatosis 2 | 55
Hepatitis 2 | 61
Hepatitis B 2 | 103
Hepatitis C 2 | 90
Inflammation 2 | 109
Inflammatory bowel disease 2 | 142
Iron deficiency anemia 2 | 6
Iron metabolism disease 2 | 17
Lung Neoplasms 2 | 171
Lung disease 2 | 132
Multiple Sclerosis 2 | 498
Nephrotic Syndrome 2 | 48
Obesity 2 | 616
Pick disease 2 | 1,893
Rheumatoid Arthritis 2 | 1,160
Schizophrenia 2 | 501
Thalassemia 2 | 46
Type 1 diabetes mellitus 2 | 101
atypical teratoid/rhabdoid tumor 2 | 1,095
ductal carcinoma in situ 2 | 1,745
esophageal adenocarcinoma 2 | 737
glioblastoma 2 | 5,572
invasive ductal carcinoma 2 | 2,950
ovarian cancer 2 | 8,484
pancreatic cancer 2 | 2,300
progressive supranuclear palsy 2 | 674
Acute myeloid leukemia, disease 1 | 16
Adenocarcinoma of lung (disorder) 1 | 48
Adult T-Cell Lymphoma/Leukemia 1 | 30
Alcohol dependence 1 | 107
Alcoholic Intoxication, Chronic 1 | 41
Animal Mammary Neoplasms 1 | 136
Anorexia 1 | 15
Beta thalassemia 1 | 19
Brain disease 1 | 83
Celiac disease 1 | 112
Common variable immunodeficiency 1 | 72
Diabetes Mellitus, Insulin-Dependent 1 | 76
Drug-Induced Liver Injury 1 | 118
Echinococcosis 1 | 28
Encephalitis 1 | 54
Fatty Liver 1 | 48
Fatty liver disease 1 | 84
Glioma 1 | 65
Herpes simplex 1 | 19
Human immunodeficiency virus infectious disease 1 | 92
Hyperactive behavior 1 | 31
Hypotension 1 | 53
Infectious mononucleosis 1 | 15
Iron Metabolism Disorders 1 | 5
Juvenile rheumatoid arthritis 1 | 104
Kidney Neoplasm 1 | 27
Leprosy 1 | 77
Liver Cirrhosis 1 | 101
Liver disease 1 | 219
Lymphatic system disease 1 | 14
Mammary Neoplasms 1 | 410
Mammary Neoplasms, Experimental 1 | 150
Measles 1 | 20
Melanoma 1 | 261
Meningitis 1 | 46
Myocardial Reperfusion Injury 1 | 34
Neoplasm Invasiveness 1 | 127
Neoplasm Metastasis 1 | 138
Neoplasms, Experimental 1 | 33
Neoplastic Cell Transformation 1 | 81
Pain 1 | 70
Relapsing remitting multiple sclerosis 1 | 14
Restless legs syndrome 1 | 28
Spinal cord disease 1 | 22
Tetanus 1 | 66
Thrombocytopenia 1 | 105
Toxic shock syndrome 1 | 28
Toxoplasmosis 1 | 16
Tropical spastic paraparesis 1 | 17
Vaccinia 1 | 37
Vitamin B12 deficiency 1 | 20
Vitiligo 1 | 71
non-inflammatory breast cancer 1 | 208
protein-losing enteropathy 1 | 11
sarcoidosis 1 | 358

Tissue

Blood and immune system 4 | 17,995
Cardiovascular System 4 | 17,958
Digestive Tract 4 | 18,473
Endocrine System 4 | 18,512
Female tissues 4 | 18,647
Male tissues 4 | 17,969
Nervous System 4 | 18,561
Respiratory system 4 | 17,484
Skin and soft tissues 4 | 18,115
Urinary Tract 4 | 18,444
Liver and Pancreas 3 | 18,136

Target Family

Non-IDG 4 | 11,971

Grant Application

1K01CA086915-01A1 4 | 4
3P41RR001209-23S1 157 | 157
5P41RR001209-22 157 | 157
5P41RR001209-23 157 | 157
2P51RR000165-51 139 | 139
5P51RR000163-52 136 | 136
5P51RR000163-51 132 | 132
5P51RR000165-50 130 | 130
2P51RR000163-50 128 | 128
5P51RR000164-48 127 | 127
5P51RR000164-50 125 | 125
5P51RR000164-49 112 | 112
5P51RR000165-49 106 | 106
5P41RR001646-19 103 | 103
5P41RR001646-20 103 | 103
7P51RR000163-41 100 | 100
2P41RR011823-16 99 | 99
5P51RR000163-42 98 | 98
5P51RR000163-43 98 | 98
5P41RR001081-24 94 | 94
5P41RR001646-18 90 | 90
5P41RR015301-09 82 | 82
5P51RR000167-49 78 | 78
5P41RR002250-26 65 | 65
5P51RR000168-40 65 | 65
5P51RR000168-41 65 | 65
5P41RR001646-27 64 | 64
5P51RR000165-40 63 | 63
5M01RR000188-45 60 | 60
3P41RR010888-05S1 59 | 59
5M01RR000030-40 58 | 58
5M01RR000096-39 57 | 57
5P41RR000954-25 57 | 57
5P41RR000954-26 57 | 57
2P41RR000954-33 56 | 56
5P41RR010888-14 56 | 56
5P41RR012408-13 55 | 55
5M01RR000188-46 53 | 53
5P41RR001646-28 52 | 52
5P51RR000167-48 52 | 52
5P51RR000168-49 52 | 52
5P41RR001646-29 51 | 51
2P41RR002250-25 50 | 50
5M01RR000188-47 50 | 50
5P51RR000166-39 47 | 47
5M01RR000043-40 46 | 46
5P51RR000168-50 46 | 46
5P41RR010888-15 45 | 45
5P41RR015301-08 45 | 45
5P41RR004050-13 44 | 44
5M01RR000847-37 43 | 43
5P41RR004050-12 43 | 43
5P51RR000167-50 43 | 43
5P51RR000169-50 43 | 43
5P41RR000954-34 42 | 42
2P41RR004050-21 41 | 41
5P41RR010888-13 41 | 41
5P51RR000168-48 41 | 41
5P51RR000167-40 40 | 40
5P41RR015301-07 39 | 39
5P51RR000164-39 39 | 39
5P51RR000168-39 39 | 39
2P51RR000169-49 38 | 38
5P51RR000169-48 38 | 38
5P41RR004050-23 37 | 37
5P51RR013986-13 37 | 37
3P51RR000167-46S2 36 | 36
5P41RR001008-25 36 | 36
5M01RR000043-49 35 | 35
5P20RR021905-04 35 | 35
5P41RR004050-22 35 | 35
5M01RR000040-40 34 | 34
5P20RR016481-10 34 | 34
5P41RR001315-19 34 | 34
3P60DE013079-01S1 32 | 32
5M01RR000833-26 32 | 32
5P20RR016481-11 32 | 32
5P20RR020152-07 32 | 32
5P41RR000862-38 32 | 32
5P51RR000166-49 32 | 32
5P60DE013079-02 32 | 32
5S06GM008037-29 32 | 32
5S06GM008037-30 32 | 32
5U41RR007707-10 32 | 32
2P20RR016480-09 31 | 31
5M01RR000827-34 31 | 31
5P41RR002250-24 31 | 31
5P41RR005959-22 31 | 31
5P41RR018522-08 31 | 31
3P60DE013079-03S1 30 | 30
5P20RR016457-10 30 | 30
5P41RR000592-40 30 | 30
5P41RR000592-41 30 | 30
5P41RR000862-36 30 | 30
5P41RR007707-17 30 | 30
5P51RR000166-48 30 | 30
5P60DE013079-03 30 | 30
5P60DE013079-04 30 | 30
5U54AI057168-09 30 | 30
5U54AI057168-10 30 | 30
2U54AI057168-06 29 | 29

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Serotransferrin TF Tchem Non-IDG -4.13136 13124.3 952
Transferrin receptor protein 1 TFRC Tbio Non-IDG -3.39868 2437.0 1167
Interleukin-2 receptor subunit alpha IL2RA Tclin Non-IDG -2.98987 913.0 1297
Interleukin-2 IL2 Tchem Non-IDG -4.34342 23652.7 1173